372
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Surface modification of zinc oxide nanoparticles with amorphous silica alters their fate in the circulation

, , , , , , & show all
Pages 720-727 | Received 02 Jul 2015, Accepted 23 Oct 2015, Published online: 19 Nov 2015

References

  • Alarifi S, Ali D, Alkahtani S, Verma A, Ahamed M, Ahmed M, Alhadlaq HA. 2013. Induction of oxidative stress, DNA damage, and apoptosis in a malignant human skin melanoma cell line after exposure to zinc oxide nanoparticles. Int J Nanomed 8:983–93
  • Alwi R, Telenkov S, Mandelis A, Leshuk T, Gu F, Oladepo S, Michaelian K. 2012. Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics. Biomed Opt Express 3:2500–9
  • Baek M, Chung HE, Yu J, Lee JA, Kim TH, Oh JM, et al. 2012. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomed 7:3081–97
  • Baek M, Kim MK, Cho HJ, Lee JA, Yu J, Chung HE, Choi SJ. 2011. Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge. J Phys: Conf Ser 304:012044
  • Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–84
  • Buesser B, Pratsinis SE. 2011. Design of gas-phase synthesis of core-shell particles by computational fluid – aerosol dynamics. AIChE J 57:3132–42
  • Buzea C, Pacheco II, Robbie K. 2007. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2:MR17–71
  • Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, et al. 2007. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 104:2050–5
  • Chen JK, Shih MH, Peir JJ, Liu CH, Chou FI, Lai WH, et al. 2010. The use of radioactive zinc oxide nanoparticles in determination of their tissue concentrations following intravenous administration in mice. The Analyst 135:1742–6
  • Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, et al. 2007. Renal clearance of quantum dots. Nat Biotechnol 25:1165–70
  • Choi SJ, Choy JH. 2014. Biokinetics of zinc oxide nanoparticles: toxicokinetics, biological fates, and protein interaction. Int J Nanomed 9 Suppl 2:261–9
  • Cohen J, Deloid G, Pyrgiotakis G, Demokritou P. 2013. Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry. Nanotoxicology 7:417–31
  • De Berardis B, Civitelli G, Condello M, Lista P, Pozzi R, Arancia G, Meschini S. 2010. Exposure to ZnO nanoparticles induces oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol Appl Pharmacol 246:116–27
  • Demokritou P, Buchel R, Molina RM, Deloid GM, Brain JD, Pratsinis SE. 2010. Development and characterization of a Versatile Engineered Nanomaterial Generation System (VENGES) suitable for toxicological studies. Inhal Toxicol 22 Suppl 2:107–16
  • Demokritou P, Gass S, Pyrgiotakis G, Cohen JM, Goldsmith W, Mckinney W, et al. 2013. An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO2 inhalation exposures. Nanotoxicology 7:1338–50
  • Djurisic AB, Leung YH. 2006. Optical properties of ZnO nanostructures. Small 2:944–61
  • Eng JK, Mccormack AL, Yates JR. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5:976–89
  • Gass S, Cohen JM, Pyrgiotakis G, Sotiriou GA, Pratsinis SE, Demokritou P. 2013. A safer formulation concept for flame-generated engineered nanomaterials. ACS Sustain Chem Eng 1:843–57
  • Jaki T, Wolfsegger MJ. 2011. Estimation of pharmacokinetic parameters with the R package PK. Pharm Stat 10:294–88
  • Jana NR, Yu HH, Ali EM, Zheng Y, Ying JY. 2007. Controlled photostability of luminescent nanocrystalline ZnO solution for selective detection of aldehydes. Chem Commun (Camb) 14:1406–8
  • Konduru NV, Jimenez RJ, Swami A, Friend S, Castranova V, Demokritou P, et al. 2015. Silica coating influences the corona and biokinetics of cerium oxide nanoparticles. Part Fibre Toxicol 12:31
  • Konduru NV, Murdaugh KM, Sotiriou GA, Donaghey TC, Demokritou P, Brain JD, Molina RM. 2014. Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles. Part Fibre Toxicol 11:44
  • Kreyling WG, Fertsch-Gapp S, Schaffler M, Johnston BD, Haberl N, Pfeiffer C, et al. 2014. In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J Nanotechnol 5:1699–711
  • Kreyling WG, Godleski JJ, Kariya ST, Rose RM, Brain JD. 1990. In vitro dissolution of uniform cobalt oxide particles by human and canine alveolar macrophages. Am J Respir Cell Mol Biol 2:413–22
  • Lynch I, Salvati A, Dawson KA. 2009. Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4:546–7
  • Moghimi SM, Hunter AC, Andresen TL. 2012. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol 52:481–503
  • Monopoli MP, Aberg C, Salvati A, Dawson KA. 2012. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779–86
  • Nohynek GJ, Dufour EK, Roberts MS. 2008. Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol Physiol 21:136–49
  • Nohynek GJ, Lademann J, Ribaud C, Roberts MS. 2007. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 37:251–77
  • Paek HJ, Lee YJ, Chung HE, Yoo NH, Lee JA, Kim MK, et al. 2013. Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo. Nanoscale 5:11416–27
  • Pavan C, Rabolli V, Tomatis M, Fubini B, Lison D. 2014. Why does the hemolytic activity of silica predict its pro-inflammatory activity? Part Fibre Toxicol 11:76
  • Peng J, Gygi SP. 2001. Proteomics: the move to mixtures. J Mass Spectrom 36:1083–91
  • Schaffler M, Semmler-Behnke M, Sarioglu H, Takenaka S, Wenk A, Schleh C, et al. 2013. Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology 24:265103
  • Schaffler M, Sousa F, Wenk A, Sitia L, Hirn S, Schleh C, et al. 2014. Blood protein coating of gold nanoparticles as potential tool for organ targeting. Biomaterials 35:3455–66
  • Schoeffner DJ, Warren DA, Muralidara S, Bruckner JV, Simmons JE. 1999. Organ weights and fat volume in rats as a function of strain and age. J Toxicol Environ Health A 56:449–62
  • Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850–8
  • Shim KH, Hulme J, Maeng EH, Kim MK, An SS. 2014. Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate. Int J Nanomed 9:217–24
  • Sotiriou GA, Watson C, Murdaugh KM, Darrah TH, Pyrgiotakis G, Elder A, et al. 2014. Engineering safer-by-design, transparent, silica-coated ZnO nanorods with reduced DNA damage potential. Environ Sci Nano 1:144–53
  • Su YK, Peng SM, Ji LW, Wu CZ, Cheng WB, Liu CH. 2010. Ultraviolet ZnO nanorod photosensors. Langmuir 26:603–6
  • Sund J, Alenius H, Vippola M, Savolainen K, Puustinen A. 2011. Proteomic characterization of engineered nanomaterial–protein interactions in relation to surface reactivity. ACS Nano 5:4300–9
  • Vuarchey C, Kumar S, Schwendener R. 2011. Albumin coated liposomes: a novel platform for macrophage specific drug delivery. Nanotechnol Dev 1:5–10
  • Warheit DB, Sayes CM, Reed KL. 2009. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures? Environ Sci Technol 43:7939–45
  • Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, et al. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2:2121–34
  • Yeh TK, Chen JK, Lin CH, Yang MH, Yang CS, Chou FI, et al. 2012. Kinetics and tissue distribution of neutron-activated zinc oxide nanoparticles and zinc nitrate in mice: effects of size and particulate nature. Nanotechnology 23:085102

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.